Caldera Capital LLC Has $368,000 Holdings in CME Group Inc. (CME)

Caldera Capital LLC cut its stake in CME Group Inc. (NASDAQ:CME) by 67.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,941 shares of the financial services provider’s stock after selling 6,042 shares during the quarter. CME Group makes up approximately 0.3% of Caldera Capital LLC’s investment portfolio, making the stock its 23rd largest position. Caldera Capital LLC’s holdings in CME Group were worth $368,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in CME. Assenagon Asset Management S.A. lifted its holdings in CME Group by 23.9% in the first quarter. Assenagon Asset Management S.A. now owns 32,675 shares of the financial services provider’s stock valued at $3,882,000 after acquiring an additional 6,311 shares during the period. World Asset Management Inc lifted its holdings in CME Group by 9.9% in the first quarter. World Asset Management Inc now owns 34,640 shares of the financial services provider’s stock valued at $4,115,000 after acquiring an additional 3,108 shares during the period. Sand Hill Global Advisors LLC lifted its holdings in CME Group by 1.5% in the first quarter. Sand Hill Global Advisors LLC now owns 41,996 shares of the financial services provider’s stock valued at $4,989,000 after acquiring an additional 625 shares during the period. British Columbia Investment Management Corp lifted its holdings in CME Group by 10.6% in the first quarter. British Columbia Investment Management Corp now owns 196,140 shares of the financial services provider’s stock valued at $23,301,000 after acquiring an additional 18,776 shares during the period. Finally, Ropes Wealth Advisors LLC lifted its holdings in CME Group by 8.7% in the first quarter. Ropes Wealth Advisors LLC now owns 10,763 shares of the financial services provider’s stock valued at $1,279,000 after acquiring an additional 859 shares during the period. 82.67% of the stock is owned by institutional investors.

Shares of CME Group Inc. (NASDAQ CME) traded down 0.63% during mid-day trading on Friday, hitting $131.29. The company had a trading volume of 1,670,615 shares. The firm has a 50-day moving average price of $126.18 and a 200 day moving average price of $122.07. CME Group Inc. has a 12 month low of $98.95 and a 12 month high of $132.34. The firm has a market capitalization of $44.63 billion, a P/E ratio of 26.80 and a beta of 0.72.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925.00 million during the quarter, compared to the consensus estimate of $931.05 million. During the same quarter in the previous year, the business earned $1.14 earnings per share. The firm’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities research analysts forecast that CME Group Inc. will post $4.81 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date is Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 53.99%.

ILLEGAL ACTIVITY WARNING: This news story was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://ledgergazette.com/2017/09/17/caldera-capital-llc-has-368000-holdings-in-cme-group-inc-cme.html.

CME has been the subject of several research analyst reports. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Friday, August 18th. Jefferies Group LLC reaffirmed a “buy” rating and set a $134.00 target price (up from $128.00) on shares of CME Group in a research note on Monday, July 17th. Royal Bank Of Canada upped their target price on CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 20th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Finally, Barclays PLC initiated coverage on CME Group in a research note on Friday, September 8th. They set an “overweight” rating and a $139.00 target price for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $132.56.

In other CME Group news, Chairman Terrence A. Duffy sold 21,815 shares of the business’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the transaction, the chairman now owns 110,711 shares in the company, valued at $13,715,985.79. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Dennis Suskind sold 750 shares of the business’s stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $129.34, for a total value of $97,005.00. Following the transaction, the director now owns 5,059 shares in the company, valued at approximately $654,331.06. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,244 shares of company stock valued at $6,021,890. 0.57% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply